172 related articles for article (PubMed ID: 17949918)
21. Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade.
Cheng X; Dib-Hajj SD; Tyrrell L; Waxman SG
Mol Pain; 2008 Jan; 4():1. PubMed ID: 18171466
[TBL] [Abstract][Full Text] [Related]
22. Genotyping microarray for CSNB-associated genes.
Zeitz C; Labs S; Lorenz B; Forster U; Uksti J; Kroes HY; De Baere E; Leroy BP; Cremers FP; Wittmer M; van Genderen MM; Sahel JA; Audo I; Poloschek CM; Mohand-Saïd S; Fleischhauer JC; Hüffmeier U; Moskova-Doumanova V; Levin AV; Hamel CP; Leifert D; Munier FL; Schorderet DF; Zrenner E; Friedburg C; Wissinger B; Kohl S; Berger W
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5919-26. PubMed ID: 19578023
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of Cav1.4 dysfunction in congenital stationary night blindness type 2.
Burtscher V; Schicker K; Novikova E; Pöhn B; Stockner T; Kugler C; Singh A; Zeitz C; Lancelot ME; Audo I; Leroy BP; Freissmuth M; Herzig S; Matthes J; Koschak A
Biochim Biophys Acta; 2014 Aug; 1838(8):2053-65. PubMed ID: 24796500
[TBL] [Abstract][Full Text] [Related]
24. An Ashkenazi Jewish founder mutation in
Kimchi A; Meiner V; Silverstein S; Macarov M; Mor-Shaked H; Blumenfeld A; Audo I; Zeitz C; Mechoulam H; Banin E; Sharon D; Yahalom C
Ophthalmic Genet; 2019 Oct; 40(5):443-448. PubMed ID: 31651202
[No Abstract] [Full Text] [Related]
25. [Establishment of the concept of new clinical entities--complete and incomplete form of congenital stationary night blindness].
Miyake Y
Nippon Ganka Gakkai Zasshi; 2002 Dec; 106(12):737-55; discussion 756. PubMed ID: 12610835
[TBL] [Abstract][Full Text] [Related]
26. Mutation screening of TRPM1, GRM6, NYX and CACNA1F genes in patients with congenital stationary night blindness.
Wang Q; Gao Y; Li S; Guo X; Zhang Q
Int J Mol Med; 2012 Sep; 30(3):521-6. PubMed ID: 22735794
[TBL] [Abstract][Full Text] [Related]
27. A novel p.Gly603Arg mutation in CACNA1F causes Åland island eye disease and incomplete congenital stationary night blindness phenotypes in a family.
Vincent A; Wright T; Day MA; Westall CA; Héon E
Mol Vis; 2011; 17():3262-70. PubMed ID: 22194652
[TBL] [Abstract][Full Text] [Related]
28. Mutations in NYX of individuals with high myopia, but without night blindness.
Zhang Q; Xiao X; Li S; Jia X; Yang Z; Huang S; Caruso RC; Guan T; Sergeev Y; Guo X; Hejtmancik JF
Mol Vis; 2007 Mar; 13():330-6. PubMed ID: 17392683
[TBL] [Abstract][Full Text] [Related]
29. Novel mutations in CACNA1F and NYX in Dutch families with X-linked congenital stationary night blindness.
Zeitz C; Minotti R; Feil S; Mátyás G; Cremers FP; Hoyng CB; Berger W
Mol Vis; 2005 Mar; 11():179-83. PubMed ID: 15761389
[TBL] [Abstract][Full Text] [Related]
30. Generalized epilepsy with febrile seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta subunit-mediated modulation of sodium channel function.
Xu R; Thomas EA; Gazina EV; Richards KL; Quick M; Wallace RH; Harkin LA; Heron SE; Berkovic SF; Scheffer IE; Mulley JC; Petrou S
Neuroscience; 2007 Aug; 148(1):164-74. PubMed ID: 17629415
[TBL] [Abstract][Full Text] [Related]
31. Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2.
Hope CI; Sharp DM; Hemara-Wahanui A; Sissingh JI; Lundon P; Mitchell EA; Maw MA; Clover GM
Clin Exp Ophthalmol; 2005 Apr; 33(2):129-36. PubMed ID: 15807819
[TBL] [Abstract][Full Text] [Related]
32. A summary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants.
Boycott KM; Maybaum TA; Naylor MJ; Weleber RG; Robitaille J; Miyake Y; Bergen AA; Pierpont ME; Pearce WG; Bech-Hansen NT
Hum Genet; 2001 Feb; 108(2):91-7. PubMed ID: 11281458
[TBL] [Abstract][Full Text] [Related]
33. Molecular determinants of frequency dependence and Ca2+ potentiation of verapamil block in the pore region of Cav1.2.
Dilmac N; Hilliard N; Hockerman GH
Mol Pharmacol; 2004 Nov; 66(5):1236-47. PubMed ID: 15286207
[TBL] [Abstract][Full Text] [Related]
34. Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca2+ channels.
Jeng CJ; Sun MC; Chen YW; Tang CY
J Cell Physiol; 2008 Feb; 214(2):422-33. PubMed ID: 17654512
[TBL] [Abstract][Full Text] [Related]
35. Photoreceptor degeneration in two mouse models for congenital stationary night blindness type 2.
Regus-Leidig H; Atorf J; Feigenspan A; Kremers J; Maw MA; Brandstätter JH
PLoS One; 2014; 9(1):e86769. PubMed ID: 24466230
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of human CNGA3 mutations associated with colour blindness suggests impaired surface expression of channel mutants A3(R427C) and A3(R563C).
Koeppen K; Reuter P; Kohl S; Baumann B; Ladewig T; Wissinger B
Eur J Neurosci; 2008 May; 27(9):2391-401. PubMed ID: 18445228
[TBL] [Abstract][Full Text] [Related]
37. The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizures.
Tokuda S; Kuramoto T; Tanaka K; Kaneko S; Takeuchi IK; Sasa M; Serikawa T
Brain Res; 2007 Feb; 1133(1):168-77. PubMed ID: 17196942
[TBL] [Abstract][Full Text] [Related]
38. Temperature dependence of T-type calcium channel gating.
Iftinca M; McKay BE; Snutch TP; McRory JE; Turner RW; Zamponi GW
Neuroscience; 2006 Nov; 142(4):1031-42. PubMed ID: 16935432
[TBL] [Abstract][Full Text] [Related]
39. Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F.
Boycott KM; Pearce WG; Bech-Hansen NT
Can J Ophthalmol; 2000 Jun; 35(4):204-13. PubMed ID: 10900517
[TBL] [Abstract][Full Text] [Related]
40. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel.
Spacey SD; Hildebrand ME; Materek LA; Bird TD; Snutch TP
Ann Neurol; 2004 Aug; 56(2):213-20. PubMed ID: 15293273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
